153 related articles for article (PubMed ID: 35815617)
41. Effect of intermittently scanned continuous glucose monitoring in people with diabetes with a psychosocial indication for initiation.
Ssemmondo E; Deshmukh H; Wilmot EG; Adeleke KA; Shah N; Walton C; Barnes D; Ryder REJ; Sathyapalan T
Diabetes Obes Metab; 2024 Apr; 26(4):1340-1345. PubMed ID: 38228571
[TBL] [Abstract][Full Text] [Related]
42. The use of isCGM leads to marked reduction in severe hypoglycemia requiring emergency medical service or hospital admission and diabetic ketoacidosis in adult type 1 diabetes patients.
Mustonen J; Rautiainen P; Lamidi ML; Lavikainen P; Martikainen J; Laatikainen T
Acta Diabetol; 2023 Jul; 60(7):891-898. PubMed ID: 36977968
[TBL] [Abstract][Full Text] [Related]
43. Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study.
Choudhary P; Kolassa R; Keuthage W; Kroeger J; Thivolet C; Evans M; Ré R; de Portu S; Vorrink L; Shin J; Habteab A; Castañeda J; da Silva J; Cohen O;
Lancet Diabetes Endocrinol; 2022 Oct; 10(10):720-731. PubMed ID: 36058207
[TBL] [Abstract][Full Text] [Related]
44. Cost-effectiveness of Continuous Glucose Monitoring for Adults With Type 1 Diabetes Compared With Self-Monitoring of Blood Glucose: The DIAMOND Randomized Trial.
Wan W; Skandari MR; Minc A; Nathan AG; Winn A; Zarei P; O'Grady M; Huang ES
Diabetes Care; 2018 Jun; 41(6):1227-1234. PubMed ID: 29650803
[TBL] [Abstract][Full Text] [Related]
45. Diabetes Knowledge and Metabolic Control in Type 1 Diabetes Starting With Continuous Glucose Monitoring: FUTURE-PEAK.
Broos B; Charleer S; Bolsens N; Moyson C; Mathieu C; Gillard P; De Block C
J Clin Endocrinol Metab; 2021 Jul; 106(8):e3037-e3048. PubMed ID: 33740049
[TBL] [Abstract][Full Text] [Related]
46. Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2018; 18(2):1-160. PubMed ID: 29541282
[TBL] [Abstract][Full Text] [Related]
47. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
[TBL] [Abstract][Full Text] [Related]
48. Efficacy of Intermittently Scanned Continuous Glucose Monitoring in the Prevention of Recurrent Severe Hypoglycemia.
Davis TME; Dwyer P; England M; Fegan PG; Davis WA
Diabetes Technol Ther; 2020 May; 22(5):367-373. PubMed ID: 31724878
[No Abstract] [Full Text] [Related]
49. Systematic Review of Randomized Controlled Trials Evaluating Glycemic Efficacy and Patient Satisfaction of Intermittent-Scanned Continuous Glucose Monitoring in Patients with Diabetes.
Cowart K; Updike W; Bullers K
Diabetes Technol Ther; 2020 May; 22(5):337-345. PubMed ID: 31859531
[No Abstract] [Full Text] [Related]
50. A European Cost-Utility Analysis of the MiniMed™ 780G Advanced Hybrid Closed-Loop System Versus Intermittently Scanned Continuous Glucose Monitoring with Multiple Daily Insulin Injections in People Living with Type 1 Diabetes.
Jendle J; Buompensiere MI; Ozdemir Saltik AZ; de Portu S; Smith-Palmer J; Pollock RF; Cohen O
Diabetes Technol Ther; 2023 Dec; 25(12):864-876. PubMed ID: 37801658
[No Abstract] [Full Text] [Related]
51. Effect of 6 Months of Flash Glucose Monitoring in Youth With Type 1 Diabetes and High-Risk Glycemic Control: A Randomized Controlled Trial.
Boucher SE; Gray AR; Wiltshire EJ; de Bock MI; Galland BC; Tomlinson PA; Rayns JA; MacKenzie KE; Chan H; Rose S; Wheeler BJ
Diabetes Care; 2020 Oct; 43(10):2388-2395. PubMed ID: 32788281
[TBL] [Abstract][Full Text] [Related]
52. Impact of coronavirus disease 2019 in seasonal variation of hemoglobin A1c in adults with type 1 diabetes and the effect of the mode of treatment: a single-center retrospective study for 2019 and 2021 and analysis by the mode of treatment.
Tanaka K; Meguro S; Itoh A; Kodani N; Itoh H
Endocr J; 2023 Aug; 70(8):787-795. PubMed ID: 37258207
[TBL] [Abstract][Full Text] [Related]
53. Non-adjunctive flash glucose monitoring system use during summer-camp in children with type 1 diabetes: The free-summer study.
Piona C; Dovc K; Mutlu GY; Grad K; Gregorc P; Battelino T; Bratina N
Pediatr Diabetes; 2018 Nov; 19(7):1285-1293. PubMed ID: 30022571
[TBL] [Abstract][Full Text] [Related]
54. Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial.
Visser MM; Charleer S; Fieuws S; De Block C; Hilbrands R; Van Huffel L; Maes T; Vanhaverbeke G; Dirinck E; Myngheer N; Vercammen C; Nobels F; Keymeulen B; Mathieu C; Gillard P
Lancet Diabetes Endocrinol; 2023 Feb; 11(2):96-108. PubMed ID: 36702566
[TBL] [Abstract][Full Text] [Related]
55. Study protocol for optimising glycaemic control in type 1 diabetes treated with multiple daily insulin injections: intermittently scanned continuous glucose monitoring, carbohydrate counting with automated bolus calculation, or both? A randomised controlled trial.
Secher AL; Pedersen-Bjergaard U; Svendsen OL; Gade-Rasmussen B; Almdal TP; Dørflinger L; Vistisen D; Nørgaard K
BMJ Open; 2020 Apr; 10(4):e036474. PubMed ID: 32345699
[TBL] [Abstract][Full Text] [Related]
56. Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes.
Jendle J; Pöhlmann J; de Portu S; Smith-Palmer J; Roze S
Diabetes Technol Ther; 2019 Mar; 21(3):110-118. PubMed ID: 30785311
[TBL] [Abstract][Full Text] [Related]
57. The effect of do-it-yourself real-time continuous glucose monitoring on psychological and glycemic variables in children with type 1 diabetes: A randomized crossover trial.
Elbalshy MM; Styles S; Haszard JJ; Galland BC; Crocket H; Jefferies C; Wiltshire E; Tomlinson P; de Bock MI; Wheeler BJ
Pediatr Diabetes; 2022 Jun; 23(4):480-488. PubMed ID: 35253331
[TBL] [Abstract][Full Text] [Related]
58. Protocol for a Randomized, Crossover Trial to Decrease Time in Hypoglycemia by Combined Intervention of the Usage of Intermittent-Scanning Continuous Glucose Monitoring Device and the Structured Education Regarding its Usage: Effect of Intermittent-Scanning Continuous Glucose Monitoring to Glycemic Control Including Hypoglycemia and Quality of Life of Patients with Type 1 Diabetes Mellitus Study (ISCHIA Study).
Suzuki S; Tone A; Murata T; Nishimura K; Miyamoto Y; Sakane N; Satoh-Asahara N; Toyoda M; Hirota Y; Matsuhisa M; Kuroda A; Kato K; Kouyama R; Miura J; Suganuma A; Tomita T; Noguchi M; Son C; Kasahara M; Ito Y; Kasama S; Hosoda K
Tokai J Exp Clin Med; 2021 Jul; 46(2):59-68. PubMed ID: 34216477
[TBL] [Abstract][Full Text] [Related]
59. Long-term Cost-Effectiveness of Dexcom G6 Real-time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Patients With Type 1 Diabetes in the U.K.
Roze S; Isitt J; Smith-Palmer J; Javanbakht M; Lynch P
Diabetes Care; 2020 Oct; 43(10):2411-2417. PubMed ID: 32647050
[TBL] [Abstract][Full Text] [Related]
60. Comparison of the clinical effects of intermittently scanned and real-time continuous glucose monitoring in children and adolescents with type 1 diabetes: A retrospective cohort study.
Urakami T; Terada H; Yoshida K; Kuwabara R; Mine Y; Aoki M; Shoji Y; Suzuki J; Morioka I
J Diabetes Investig; 2022 Oct; 13(10):1745-1752. PubMed ID: 35532954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
